logo

For the Inventor, By the Inventor

Seoul, South Korea

Ki Sun Roh

This inventor holds 1 USPTO granted patent. Top assignee: Medifron Dbt Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ki Sun Roh. Retrieved from https://idiyas.com/inventor/ki-sun-roh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:

goldMedal1 out of 2 
 
Medifron Dbt Inc.
 patents

Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents
1. 12692260 - Compound having inhibitory activity against O-glusacase and use thereof (2026-07-28),

Title: Ki Sun Roh: Inventor in O-GlcNAcase Inhibitor Research

Introduction

Ki Sun Roh is an inventor based in Seoul, South Korea. His patent work includes a compound with inhibitory activity against O-GlcNAcase and its potential use.

Latest Patents

Roh is associated with 1 patent: “Compound Having Inhibitory Activity Against O-GlcNAcase and Use Thereof.” The invention concerns a novel compound that inhibits O-GlcNAcase and describes its use.

Career Highlights

Roh is associated with Medifron DBT Inc. His listed patent reflects work on compounds targeting O-GlcNAcase.

Collaborations

His listed coworkers include Hee Kim and Hee Jin Ha.

Conclusion

Ki Sun Roh’s patent activity centers on an O-GlcNAcase-inhibiting compound, developed in connection with Medifron DBT Inc.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…